Exelixis (EXEL) EBT (2010 - 2026)
Exelixis' (EXEL) quarterly EBT came in at $267.7 million in Q2 2026, up 30.14% year-on-year from $205.7 million in Q2 2025, and up 5.94% quarter-over-quarter from $252.7 million in Q1 2026.
Exelixis (EXEL) EBT (2010 - 2026) Analysis & Trends
Exelixis' EBT history runs 17 years deep, the most recent figure standing at $267.7 million for Q2 2026.
- On a quarterly basis, EBT rose 30.14% year-over-year to $267.7 million in Q2 2026; TTM through Apr 2026 was $1.0 billion, a 19.7% increase from a year earlier, with the FY2026 full-year figure at $941.2 million, up 38.08% from the prior year.
- EBT improved to $267.7 million in Q2 2026 per EXEL's latest filing, from $252.7 million in the prior quarter.
- Across five years, EBT topped out at $292.8 million in Q2 2024 and bottomed at -$31.4 million in Q4 2022.
- The 5-year median for EBT is $103.0 million (2023), against an average of $140.1 million.
- Biggest YoY gain for EBT was 4329.73% in 2022; the steepest drop was 126.63% in 2022.
- Year by year, EBT stood at -$31.4 million in 2022, then surged by 427.87% to $103.0 million in 2023, then soared by 50.19% to $154.8 million in 2024, then surged by 63.1% to $252.4 million in 2025, then climbed by 6.05% to $267.7 million in 2026.
- Per Business Quant, the three latest EXEL EBT figures stand at $267.7 million (Q2 2026), $252.7 million (Q1 2026), and $252.4 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 267.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 267.69 Mn |
| Jan 2, 2026 | 252.69 Mn |
| Oct 3, 2025 | 252.41 Mn |
| Jul 4, 2025 | 230.42 Mn |
| Apr 4, 2025 | 205.69 Mn |
| Jan 3, 2025 | 184.77 Mn |
| Sep 27, 2024 | 154.76 Mn |
| Jun 28, 2024 | 292.85 Mn |
| Mar 29, 2024 | 49.27 Mn |
| Dec 29, 2023 | 103.04 Mn |
| Sep 29, 2023 | 5.82 Mn |
| Jun 30, 2023 | 100.39 Mn |
| Mar 31, 2023 | 48.28 Mn |
| Dec 30, 2022 | -31.43 Mn |
| Sep 30, 2022 | 92.04 Mn |
| Jul 1, 2022 | 88.51 Mn |
| Apr 1, 2022 | 85.23 Mn |
| Dec 31, 2021 | 118.02 Mn |
| Oct 1, 2021 | 53.26 Mn |
| Jul 2, 2021 | 124.89 Mn |